SNGX Stock Analysis: Buy, Sell, or Hold?

SNGX - Soligenix, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.39
-0.01 (-2.52%) ▼
5d: -2.03%
30d: -48.32%
90d: -66.35%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026

Get Alerted When SNGX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: SNGX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: SNGX is currently trading at $0.39, which is considered slightly low relative to its 30-day fair value range of $0.33 to $0.68.

Technical Outlook: Technically, SNGX is in a strong downtrend. The price is currently testing key support at $0.41. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.75 (+352.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $0.33 - $0.68
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.6%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 352.2% below Wall St target ($1.75)

Trading Range Analysis

30-Day Trading Range $0.33 - $0.68
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $0.41
Resistance Level $1.13
Current Trend Strong Downtrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.55
Wall Street Target $1.75 (+352.2%)
Revenue Growth (YoY) -100.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 04, 2026 9:59 PM ET
Data refreshes hourly during market hours. Next update: 10:58 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SNGX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$436 64 BUY
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 56 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$102 62 BUY
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$31 58 HOLD
BHVN
Biohaven Ltd.
STRONG BUY
16 analysts
$22 57 HOLD

More Analysis for SNGX

SNGX Technical Chart SNGX Price Prediction SNGX Earnings Date SNGX Investment Advisor SNGX Fair Price Analyzer SNGX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals